Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 20/20 | 0.45 |
| ▸ | OXTR | P30559 | 11/20 | 0.45 |
| ▸ | AVPR2 | P30518 | 4/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1496046 | 0.94 | AVPR1A (0.43) | AVPR1AOXTRAVPR2CHRM2CHRM4 | |
| SCHEMBL1496034 | 0.92 | AVPR1A (0.43) | AVPR1AOXTRAVPR2CHRM2CHRM4 | |
| SCHEMBL1496081 | 0.92 | AVPR1A (0.45) | AVPR1AOXTRAVPR2CHRM2CHRM4 | |
| SCHEMBL1496103 | 0.91 | AVPR1A (0.44) | AVPR1AOXTRAVPR2CHRM2CHRM4 | |
| SCHEMBL1495996 | 0.90 | AVPR1A (0.45) | AVPR1AOXTRAVPR2CHRM2CHRM4 | |
| SCHEMBL1496146 | 0.90 | AVPR1A (0.43) | AVPR1AOXTRAVPR2CHRM2CHRM4 | |
| SCHEMBL1496024 | 0.89 | AVPR1A (0.43) | AVPR1AOXTRAVPR2CHRM2CHRM4 | |
| SCHEMBL1496276 | 0.86 | AVPR1A (0.41) | AVPR1AOXTRAVPR2CHRM2CHRM4 | |
| SCHEMBL1496007 | 0.84 | AVPR1A (0.42) | AVPR1AOXTRAVPR2 | |
| SCHEMBL1496129 | 0.84 | AVPR1A (0.43) | AVPR1AOXTRAVPR2CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2292621-A1 | Vasopressin v1a antagonists | Vantia Limited (GB) | 2011-03-09 | — | — | EP | claimed |